BRD4 and neoplasm: In contrast, PGD7 NPs remarkably suppressed BRD4 expression in vivo by ~80% in the tumour tissue (Fig. 4h and Supplementary Fig. 34a) due to the improved delivery efficacy of ARV771 from the POLY-PROTAC NPs.